Search results (52)
« Back to PublicationsHeritable genetic variants in key cancer genes link cancer risk with anthropometric traits.
Journal article
Di Giovannantonio M. et al, (2021), Journal of medical genetics, 58, 392 - 399
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.
Journal article
Zhang P. et al, (2021), Cancer research, 81, 1667 - 1680
miRNAs in the 14q32 cluster are involved in lapatinib resistance
Conference paper
(2019), American Association for Cancer Research Annual Meeting 2017
Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits
Preprint
Di Giovannantonio M. et al, (2019)
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response
Journal article
Zhang P. et al, (2019)
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.
Journal article
MacGregor TP. et al, (2018), Scientific reports, 8
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.
Journal article
Schwerd T. et al, (2018), Mucosal immunology, 11, 562 - 574
Mammalian γ2 AMPK regulates intrinsic heart rate.
Journal article
Yavari A. et al, (2017), Nature communications, 8
The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Journal article
Wilson S. et al, (2017), Oncotarget, 8, 30328 - 30343
Impact of IL-27 on hepatocyte antiviral gene expression and function.
Journal article
Ramamurthy N. et al, (2016), Wellcome open research, 1
Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Journal article
Fan L. et al, (2016), Oncogene, 35, 2441 - 2452
A ROLE FOR HISTONE DEMETHYALASE JMJD1A IN THE DNA DAMAGE RESPONSE OF PROSTATE CANCER CELLS
Conference paper
Fan L. et al, (2016), JOURNAL OF UROLOGY, 195, E1146 - E1146
Histone demethyalase JMJD1A promotes the DNA damage response of prostate cancer cells
Conference paper
Fan L. et al, (2016), CANCER RESEARCH, 76
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Journal article
Dolatshad H. et al, (2015), Leukemia, 29
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.
Journal article
Taylor JC. et al, (2015), Nature genetics, 47, 717 - 726
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
Journal article
Dolatshad H. et al, (2015), Leukemia, 29, 1092 - 1103
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Journal article
Dolatshad H. et al, (2015), Leukemia, 29, 1092 - 1103
Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation.
Journal article
McNeill E. et al, (2015), Free radical biology & medicine, 79, 206 - 216
The histone demethylase JMJD1A is essential to prostate cancer cells through regulation of c-Myc expression
Conference paper
Fan L. et al, (2015), CANCER RESEARCH, 75
CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.
Journal article
Fergusson JR. et al, (2014), Cell reports, 9, 1075 - 1088